Llwytho...
In Vitro and In Vivo Anticancer Activity of Gimatecan against Hepatocellular Carcinoma
OBJECTIVE: Gimatecan is a new camptothecin (CPT) analogue that inhibits tumor growth by targeting DNA topoisomerase I (TOP I) and introducing strong and persistent DNA cleavage. Anti-tumor activity has been demonstrated with a wide range of solid tumors in previous preclinical and clinical studies....
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Asian Pac J Cancer Prev |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
West Asia Organization for Cancer Prevention
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5454685/ https://ncbi.nlm.nih.gov/pubmed/28030910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2016.17.11.4853 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|